CHANG-TSU YUANTAI-CHUNG HUANGChuang C.-C.Chuang Y.-K.JIA-HUEI TSAIJAU-YU LIAUCHUNG-WU LINJIH-LUH TANG2020-03-032020-03-0320190390-6078https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072848750&doi=10.3324%2fhaematol.2018.215327&partnerID=40&md5=aca559922a72a5760de24dee0e2df450https://scholars.lib.ntu.edu.tw/handle/123456789/468837[SDGs]SDG3asparaginase; BLLF1 glycoprotein; CD2 antigen; CD3 antigen; CD5 antigen; CD8 antigen; daratumumab; dexamethasone; DNA methyltransferase 3A; EBV encoded small RNA1; fluorodeoxyglucose f 18; gemcitabine; glycoprotein; granzyme B; latent membrane protein 1; lymphocyte receptor; methotrexate; Myc protein; nivolumab; nucleolysin TIA 1 isoform p40; oxaliplatin; polycomb repressive complex 2; programmed death 1 ligand 1; protein p53; small interfering RNA; STAT3 protein; STAT5b protein; Tet methylcytosine dioxygenase 2; transcription factor EZH2; unclassified drug; DNA binding protein; oncoprotein; TET2 protein, human; aged; Article; cancer chemotherapy; case report; cell infiltration; clinical article; clonal evolution; congenital skin disease; DNMT3A gene; Epstein Barr virus; erythema; facial plaque; gene frequency; gene mutation; gene overexpression; gene rearrangement assay; gene sequence; genetic analysis; histone methylation; human; human tissue; immunohistochemistry; in situ hybridization; JAK-STAT signaling; loss of function mutation; lymphoid cell; lymphoma involvement; male; necrosis; next generation sequencing; NK T cell lymphoma; nose epithelium; nose tumor; oncogene c myc; papule; phenotype; positron emission tomography; protein phosphorylation; pseudoepitheliomatous hyperplasia; real time polymerase chain reaction; Sanger sequencing; sequence alignment; sequence analysis; skin defect; squamous cell carcinoma; squamous pseudoepitheliomatous hyperplasia; T-cell gene rearrangement; tumor biopsy; tumor localization; upregulation; genetics; metabolism; NK T cell lymphoma; Aged; DNA-Binding Proteins; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Proto-Oncogene Proteinsjournal article10.3324/haematol.2018.215327310976312-s2.0-85072848750